Search

everythinglearnresearchcommunity

for

Search:↓

The new follicular unit extraction treatment effectively treats severe hair loss in Asian men, giving natural-looking results with few side effects.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

People with alopecia have shorter hair follicles and more c-kit, a stem cell factor receptor, which could predict how the condition progresses.

Low-level laser therapy is safe but not significantly better than minoxidil alone for hair growth.

Androgenetic alopecia significantly affects mental health and quality of life, highlighting the need for psychiatric evaluations.

Androgenetic alopecia negatively affects quality of life, especially in younger, less educated, single, and rural individuals.

Using platelet-rich plasma injections and biotin pills together significantly increases hair regrowth in men with hair loss.

People with androgenetic alopecia have a higher risk of heart disease.

Platelet Rich Plasma (PRP) injections can improve hair count, thickness, and strength in people with androgenic alopecia.

Body hair transplants can treat baldness but differ from scalp hair and need more research on long-term results and side effects.

Light therapy can stimulate hair growth and is more effective when started early, but more research is needed on its long-term effects and optimal use.

The treatment improved hair growth in three patients with alopecia.

Topical finasteride is an effective and safer treatment for male hair loss.

Non-coding RNAs are important for hair growth and could lead to new hair loss treatments, but more research is needed.

Mesotherapy is not significantly better than minoxidil for treating male hair loss.

Giant axonal neuropathy changes the structure of keratin in human hair.

Androgenetic alopecia requires a personalized treatment plan and psychological support to improve quality of life.

The conclusion is that more hair loss (androgenetic alopecia) is linked to larger prostate size, suggesting hair loss could be an early sign of benign prostatic hyperplasia.

Hair loss reduces hair thickness and coverage, but drug treatments mainly revive dormant hairs rather than reverse thinning; patients often undervalue their hair loss severity.

The new topical botanical formulation significantly regrew hair in all five patients without side effects.

Androgenetic alopecia causes significant psychological distress, especially in women, and requires both medical and psychological support.

Hair loss is more common in male Chinese college freshmen, and it's linked with rosacea but doesn't affect their quality of life.

Botulinum Toxin Type A can increase hair density and improve hair thickness in androgenetic alopecia with minimal side effects.

Androgenetic alopecia treatments slightly increase the risk of side effects, especially sexual dysfunction and skin reactions.

Autologous Micrografting Technology effectively improves hair growth and is a safe, promising option for hair restoration.

Exosome therapy can safely and effectively restore color to gray hair.

Both treatments improved hair quality and thickness equally, with mild side effects.

Androgenetic alopecia may indicate higher risk for certain diseases and mental health issues.

Metformin lowers prolactin in men with normal hair but not in those with early hair loss.